[1]
Fadhel A. Shehab et al. 2024. Impact of Gliclazide Modified Release or Glimepiride as Add-on Therapy to Metformin on Glycemic and Oxidative Stress Parameters in Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences. 33, 2 (Jun. 2024), 20–30. DOI:https://doi.org/10.31351/vol33iss2pp20-30.